Sep 26, 2020
What does the evidence say on the safety and immunogenicity of the new Novavax vaccine for the SARS-CoV-2 infection?
Sep 17, 2020
Is cell phone location data associated with the rate of change in new COVID-19 cases by county across the US? Tune in to what the evidence say.
Sep 11, 2020
An open-label, non-randomized, single-arm, Expanded Access Program (EAP) trial conducted to explore potential signals of efficacy of COVID-19 convalescent plasma.
Read more here: inpharmd.com/covid
Sep 2, 2020
A prospective, multi-center, single-blind, randomized controlled phase II trial assessing the efficacy and safety of ruxolitinib in hospitalized COVID-19 patients